Response to "Emodin in Skeletal Muscle Ischemia-Reperfusion: Model Validity and Analytical Concerns" [Response to Letter].

Yiğit D, Oktar GL, Demirtaş H, Özer A, Küçük A, Yığman Z, Tekin E, Arslan M

Open source

DOI
10.2147/dddt.s659972
Published
2026
Container
Drug design, development and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s659972,
  title = {Response to "Emodin in Skeletal Muscle Ischemia-Reperfusion: Model Validity and Analytical Concerns" [Response to Letter].},
  author = {Yiğit D and Oktar GL and Demirtaş H and Özer A and Küçük A and Yığman Z and Tekin E and Arslan M},
  year = {2026},
  journal = {Drug design, development and therapy},
  doi = {10.2147/dddt.s659972},
  url = {https://doi.org/10.2147/dddt.s659972}
}

RIS

TY  - JOUR
TI  - Response to "Emodin in Skeletal Muscle Ischemia-Reperfusion: Model Validity and Analytical Concerns" [Response to Letter].
AU  - Yiğit D
AU  - Oktar GL
AU  - Demirtaş H
AU  - Özer A
AU  - Küçük A
AU  - Yığman Z
AU  - Tekin E
AU  - Arslan M
PY  - 2026
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s659972
UR  - https://doi.org/10.2147/dddt.s659972
ER  - 

APA

D, Y., GL, O., H, D., A, Ö., A, K., Z, Y., E, T., & M, A. (2026). Response to "Emodin in Skeletal Muscle Ischemia-Reperfusion: Model Validity and Analytical Concerns" [Response to Letter].. Drug design, development and therapy. https://doi.org/10.2147/dddt.s659972

Source records